skip to main | skip to sidebar

Bank of Research

About Us: Bank of Research (BOR) is an autonomous investment blogspot to guide Investors for Indian listed equity. Our mission is to unearth investment opportunities leveraging on our fact-search, timely, and actionable research. We use our knowledge & network to identify long-term investment opportunities

Wednesday, December 24, 2008

BROKERAGE CALLS

Buy Piramal Healthcare, target of Rs 340: Angel
Buy Bajaj Hindusthan, target of Rs 85: Karvy
Hold HCL Tech, target of Rs 144: Emkay Global
Buy Tamil Newsprint, target of Rs 96: Karvy
Hold Glenmark Pharma: Sharekhan
Accumulate Lupin, target of 656: Religare

allvoices
Posted by Prashanth Tapse at 11:30:00 AM

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

StatCounter

Stock Markets

  • Brokerage Report & Targets
  • BSE Bulk Deals Daily update
  • BSE India
  • BSE Indices Watch
  • BSE Intraday Block Deals
  • Currencies Exg Rates Live
  • Economic Times
  • European markets
  • Latest Corp Announcements
  • Live Crude Prices
  • Live Gold Price chart
  • Live Indian Gold price
  • Live SGX Nifty Index Futures
  • Live TV / CNBC TV18
  • Market Trend
  • Money Control
  • Nse India
  • Stock Ideas for investments
  • Technical Bazaar
  • The hindu businessline
  • Upcoming Broad Meetings
  • Updates Recent Qtr ended results
  • Windows 7 TuneUp

Blog Archive

Contact

  • Basanth Patil
  • Prashanth Tapse
  • Rohan Gala
  • Yashavanth Patil G S
 

What do you fell about markets ?

Disclaimer & Disclosure....

Disclaimer :-
Trading or investing in stocks & commodities is a high risk activity. Any action you choose to take in the markets is totally your own responsibility, www.bankofresearch.blogspot.com will not be liable for any, direct or indirect, consequential or incidental damages or loss arising out of the use of this information.

Disclosure :-
The information on this website is neither an offer to sell nor solicitation to buy any of the securities mentioned herein. The writers may or may not be trading in the securities mentioned.